<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01615276</url>
  </required_header>
  <id_info>
    <org_study_id>MEC 12-3-020</org_study_id>
    <nct_id>NCT01615276</nct_id>
  </id_info>
  <brief_title>Neuromuscular Electrical Stimulation (NMES) and Muscle Protein Accretion (ES-PRO)</brief_title>
  <acronym>ES-PRO</acronym>
  <official_title>The Effect of Neuromuscular Electrical Stimulation on Post-prandial Muscle Protein Accretion in Healthy Elderly Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present study, the effect of a bolus of intrinsically labeled milk directly after
      one-legged NMES will be studied.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tracer enrichment in the muscle biopsy</measure>
    <time_frame>4 hours after protein ingestion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fractional synthetic rate (FSR)</measure>
    <time_frame>0-4 hours after protein ingestion</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Protein ingestion</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Protein ingestion directly after the contralateral leg received NMES</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protein ingestion after NMES</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ingestion of intrinsically labeled protein, directly after one hour of Neuromuscular electrical stimulation (NMES)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Enraf Nonius Tensmed S84 for Neuromuscular electrical stimulation (NMES)</intervention_name>
    <description>One our of one-legged neuromuscular electrical stimulation (NMES)</description>
    <arm_group_label>Protein ingestion after NMES</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>No Enraf Nonius Tensmed S84 for Neuromuscular electrical stimulation (NMES) NMES</intervention_name>
    <description>No neuromuscular electrical stimulation (NMES) will be applied in the control leg</description>
    <arm_group_label>Protein ingestion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  Age 65 - 85 years

          -  18.5 &lt; BMI &lt; 30 kgâˆ™m2

        Exclusion Criteria:

          -  Type II diabetes

          -  All co morbidities interacting with mobility and muscle metabolism of the lower limbs
             (e.g. arthrosis, arthritis, spasticity/rigidity, all neurological disorders,
             paralysis, hip/knee surgery).

          -  Use of anticoagulants, blood diseases, allergy for lidocaine

          -  Use of NSAIDs and acetylsalicylic acid

          -  Patients suffering from PKU (Phenylketonuria)

          -  Presence of implantable cardioverter defibrillator and/or pacemaker

          -  Performed regular resistance type exercise in the past 6 months
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luc JC van Loon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht UMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht University Medical Centre</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2012</study_first_submitted>
  <study_first_submitted_qc>June 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2012</study_first_posted>
  <last_update_submitted>May 30, 2013</last_update_submitted>
  <last_update_submitted_qc>May 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuromuscular Electrical Stimulation</keyword>
  <keyword>Ageing</keyword>
  <keyword>Protein ingestion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

